Amneal Pharma A earnings beat by $0.05, revenue fell short of estimates

  • Investing.com
Amneal Pharma A earnings beat by $0.05, revenue fell short of estimates
Credit: © Reuters.

Investing.com - Amneal Pharma A (NASDAQ: AMRX ) reported first quarter EPS of $0.140, $0.05 better than the analyst estimate of $0.090. Revenue for the quarter came in at $617M versus the consensus estimate of $634.89M.

Guidance

Amneal Pharma A sees FY 2024 EPS of $0.530-$0.630 versus the analyst consensus of $0.590.

Amneal Pharma A sees FY 2024 revenue of $2.550B-$2.650B versus the analyst consensus of $2.580B.

Amneal Pharma A's stock price closed at $5.520. It is up 18.450% in the last 3 months and up 177.390% in the last 12 months.

Amneal Pharma A saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Amneal Pharma A's stock price’s past reactions to earnings here.

According to InvestingPro, Amneal Pharma A's Financial Health score is "good performance".

Check out Amneal Pharma A's recent earnings performance , and Amneal Pharma A's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles